Comparison Of Percutaneous Mechanical Thrombectomy With Different Access in Treatment of Acute Deep Venous Thrombosis

Recruiting Observational Study
Deep Vein Thrombosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Observational
Participants needed
210 (estimated)
Sponsor
RenJi Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The study aims to compare the modified approach through ipsilateral deep calf venous access or contralateral femoral venous access with the traditional approach through ipsilateral popliteal venous access for iliofemoral deep venous thrombosis (DVT) with distal popliteal vein thrombosis, and determine whether it can achieve similar therapeutic effects as iliofemoral DVT without distal popliteal ve…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age between 18-85 years old; 2. Acute DVT occurred no more than 14 days since the onset of disease; 3. DVT treated by percutaneous mechanical thrombectomy 4. Informed consent signed by patients. Exclusion Criteria: 1. Patients who are known to be allergic to heparin, low mo…
Contacts

Ni Qihong, M.D.

+8615801900772

niqihong1989@163.com

CONTACT